Related Experiment Video
Updated: Jan 2, 2026

Evaluation of Amino Acid Consumption in Cultured Bone Cells and Isolated Bone Shafts
Published on: April 13, 2022
Activation of Oxidative Stress Response in Cancer Generates a Druggable Dependency on Exogenous Non-essential Amino
Sarah E LeBoeuf1, Warren L Wu1, Triantafyllia R Karakousi1
1Department of Pathology, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA.
Abstract:
Rewiring of metabolic pathways is a hallmark of tumorigenesis as cancer cells acquire novel nutrient dependencies to support oncogenic growth. A major genetic subtype of lung adenocarcinoma with KEAP1/NRF2 mutations, which activates the endogenous oxidative stress response, undergoes significant metabolic rewiring to support enhanced antioxidant production. We demonstrate that cancers with high antioxidant capacity exhibit a general dependency on exogenous non-essential amino acids (NEAAs) that is driven by the Nrf2-dependent secretion of glutamate through system xc- (XCT), which limits intracellular glutamate pools that are required for NEAA synthesis. This dependency can be therapeutically targeted by dietary restriction or enzymatic depletion of individual NEAAs. Importantly, limiting endogenous glutamate levels by glutaminase inhibition can sensitize tumors without alterations in the Keap1/Nrf2 pathway to dietary restriction of NEAAs. Our findings identify a metabolic strategy to therapeutically target cancers with genetic or pharmacologic activation of the Nrf2 antioxidant response pathway by restricting exogenous sources of NEAAs.
Insights
Lung adenocarcinoma with KEAP1/NRF2 mutations depends on non-essential amino acids (NEAAs) due to Nrf2-driven glutamate secretion. Restricting NEAAs or glutamate offers a targeted therapy approach.
Area of Science:
- Oncology
- Metabolic pathways
- Cancer metabolism
Background:
- Tumorigenesis involves metabolic pathway rewiring, leading to nutrient dependencies.
- KEAP1/NRF2-mutated lung adenocarcinoma activates oxidative stress response, requiring metabolic adaptations for antioxidant production.
Purpose of the Study:
- To investigate the metabolic dependencies of cancers with high antioxidant capacity.
- To identify therapeutic strategies targeting NRF2-activated lung adenocarcinoma.
Main Methods:
- Analysis of metabolic rewiring in KEAP1/NRF2-mutated lung adenocarcinoma.
- Investigating the role of Nrf2-dependent glutamate secretion via system xc- (XCT).
- Evaluating therapeutic targeting through dietary restriction or enzymatic depletion of NEAAs and glutaminase inhibition.
Main Results:
- Cancers with high antioxidant capacity exhibit dependency on exogenous non-essential amino acids (NEAAs).
- Nrf2-driven glutamate secretion via XCT limits intracellular glutamate for NEAA synthesis.
- Dietary restriction or enzymatic depletion of NEAAs, and glutaminase inhibition, show therapeutic potential.
Conclusions:
- Nrf2-activated cancers have a specific dependency on exogenous NEAAs.
- Targeting NEAA metabolism or glutamate synthesis presents a viable therapeutic strategy for NRF2-driven cancers.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Treatment Resistant Cancers
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

